What is American Well's latest dividend and current dividend yield?

What were the key takeaways from American Well’s earnings call?

What is American Well's gross profit margin?

What guidance did American Well's management provide for the next earnings period?

What does American Well do and what are its main business segments?

What is the revenue and EPS growth rate for American Well year over year?

What is the market's earnings forecast for American Well next quarter?

What were the key takeaways from American Well's earnings call?

- **Revenue Growth**: Q3 subscription revenue up 18% YoY, driven by virtual primary care expansion. 
- **AI Impact**: AI reduces 30-day readmissions by 50% and enables $500/patient savings for payers. 
- **Financial Health**: Gross margin expands to 52%, with $201M cash on hand and no debt. 
- **2026 Target**: On track for cash flow breakeven through cost cuts and AI-driven efficiency. 
- **Customer Win**: Secured Florida Blue deal by solving vendor fragmentation challenge. 


**【CEO Summary Section】**
- **Strategic Focus**: AmWell is prioritizing two main initiatives: (1) developing a next-generation, enterprise-grade platform with AI integration and (2) optimizing operational efficiency to achieve cash flow breakeven by end-2026. 
- **Market Momentum**: Q3 2025 results reflect stronger subscription retention and visit volume in virtual primary care. AI-driven solutions are reducing 30-day readmissions by 50% and generating high customer satisfaction (NPS scores). 
- **Customer Wins**: Secured a major Florida Blue deal by offering a unified platform that reduces vendor fragmentation and complexity. 
- **Legacy Assets**: Will continue supporting legacy solutions (e.g., inpatient telehealth) but redirect resources to high-margin clinical programs like virtual primary care and behavioral health. 

**【CFO Financial Commentary】**
- **Q3 2025 Results**: 
  - Total revenue: $56.3M (down 8% YoY, but +1.3% when excluding APC sale)
  - Subscription revenue: $30.9M (+18% YoY, 55% of total revenue)
  - Gross margin: 52% (vs. 37% YoY)
  - Adjusted EBITDA: -$12.7M (vs. -$31M YoY)
  - Cash burn: $18M (ending Q3 with $201M cash)
- **Cost Optimization**: 
  - R&D expenses down 6%
  - Sales & marketing down 46%
  - G&A expenses down 14%
- **2025 Guidance Update**: 
  - Full-year revenue: $245-248M (vs. prior $245-250M)
  - Q4 revenue: $51-54M
  - Adjusted EBITDA: -$15M to -$12M
- **2026 Outlook**: Targeting positive cash flow from operations through continued expense reduction and margin expansion.

**【Q&A Highlights】**
1. **AI Monetization**: 
   - Integrates AI into clinical programs (e.g., predictive readmission models) to reduce costs and improve outcomes. 
   - Monetizes through program referrals (e.g., 30-day readmission savings sharing) rather than direct platform fees. 
2. **Divestiture Strategy**: 
   - Actively exploring sales of non-core assets (e.g., inpatient telehealth) to focus on high-growth clinical programs. 
   - No immediate impact on 2025 guidance, but could accelerate 2026 cash flow. 
3. **Macroeconomic Impact**: 
   - Health systems prioritize value-based care solutions despite IT budget caution. 
   - Minimal tariff exposure; U.S.-based software development limits trade risks. 
4. **Customer Retention**: 
   - 79% of Gen Z now use health tech monthly, driving demand for AmWell's personalized care navigation. 
   - AI-driven program matching improves member engagement and reduces churn. 


American Well Corporation (AMWL) Q3 2025 Earnings Call Transcript

Revenue

Sales and Services Revenue

Financing Services Revenue

Other Revenue

Cost of Revenue

Cost of Goods and Services

Cost of Financing Services

Other Cost

Gross Profit

Other Operating Income

Operating Expenses

Selling, General and Administrative Expenses

Selling and Marketing Expenses

General and Administrative Expenses

Research and Development Expenses

Loss on Bad Debts

Loss on Impairment of Other Assets

Loss on Disposal of Assets

Other Operating Expenses

Operating Income

Non-Operating Income (Loss)

Income (Loss) from Affiliates

Income (Loss) from Associates

Income (Loss) from Joint ventures

Gain (Loss) on Other Investment

Gain (Loss) on Change in Fair Value

Gain (Loss) on Foreign Currency Exchange

Other Non-Operating Income (Loss)

Net Interest Expense

Interest Expense

Interest Income

Pretax Income From Continuing Operations

Income Tax Expense

Current Income Tax

Deferred Income Tax

Income Tax Adjustments

Net Income from Continuing Operations

Income from Discontinued Operations

Other Items Before Net Income

Net Income

Net Income Attributable to Minority Interests

Net Income Attributable to Owners of the Company

Preferred Stock Dividends

Other Adjustments

Net Income Attributable to Common Stockholders

Other Comprehensive Income

Total Comprehensive Income

Total Comprehensive Income Attributable to Minority Interests

Total Comprehensive Income Attributable to Owners of the Company

Basic EPS

Basic EPS from Continuing Operations

Basic EPS from Discontinued Operations

Diluted EPS

Diluted EPS from Continuing Operations

Diluted EPS from Discontinued Operations

AMWL

AMWL fundamentals

You can ask Aime